Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2011-05-18

FDA Approved: INTROVALE — Supplemental Application (Xiromed, LLC.)

View source ↗

Summary

FDA approved a supplemental application for INTROVALE (levonorgestrel and ethinyl estradiol) from Xiromed, LLC., for this combined oral contraceptive.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • INTROVALE (Levonorgestrel and Ethinyl Estradiol)

Snippet

SUPPL AP for INTROVALE (LEVONORGESTREL AND ETHINYL ESTRADIOL)